SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending due to its pivot towards quantum computing for cryptocurrency applications, generating excitement around energy-efficient blockchain infrastructure. The community is discussing the potential of LightSolver's laser-based processing units and comparing QCLS to other quantum and crypto-related stocks. Traders are monitoring the stock's threshold list status and anticipating news regarding partnerships and potential contract announcements.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending due to discussions around a potential short squeeze and unusual options activity, indicating bullish sentiment. Community members are debating the company's valuation and future prospects in the quantum computing sector, while also referencing collaborations with companies like NVIDIA. Concerns around cash burn and potential dilution are being weighed against the potential for significant growth and government contracts in the burgeoning quantum computing industry.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid a flurry of activity in the quantum computing sector, including major acquisitions and significant funding rounds for competitors. Community members are actively discussing the potential impact of these developments on QBTS, along with its existing partnerships and recent successes in applying quantum computing to real-world problems. Bullish sentiment is fueled by the belief that QBTS is undervalued compared to peers and poised for significant growth as quantum technology gains wider adoption.

Aventus Network

Aventus Network ($AVT) is trending as traders discuss its low market cap, real-world partnerships with Vodafone and Heathrow, and integration with Polkadot; some community members believe $AVT is undervalued and poised for a breakout. Bullish sentiment surrounds the token, with traders closely monitoring volume as a key indicator, while also pointing to the potential of its appchain model. Some are speculating about a potential pump with a government shutdown and are hoping for new all time highs soon.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to recent purchase orders for its quantum computing systems, signaling growing commercial adoption. The community is actively discussing the stock's high valuation relative to sales and its potential within the rapidly evolving quantum computing sector. Bullish sentiment and comparison to other high-growth tech stocks are also prevalent talking points.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community emphasizes its role as a culture coin, promoting freedom and creativity. Discussions highlight its movement within the Solana ecosystem, drawing comparisons to Bitcoin. Community members are sharing links to the Weedcoin website and Dexscreener.

Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.

Bakkt Holdings Inc - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is trending due to renewed interest in its strategic direction as a pure-play crypto company and the appointment of a fintech veteran to its board. The community is actively discussing the potential for a short squeeze and speculating on partnerships and expansion, contributing to bullish sentiment and potential price targets. Some traders are also attributing the stock's rise to strength in Bitcoin and broader crypto market trends.

A multi-agent AI platform dissecting human nature’s first principles through iterative survival challenges and data-driven insights. Core dev has access to one of the founding partners of Two Sigma Ventures - the VC company of one of the biggest hedge funds in the world. Plans to raise seed round and scale after building organic foundation. Project devs are from academia space and are trying to bridge the gap between crypto and academia.

CortexZero

CortexZero is gaining attention, with the community highlighting its potential for a breakout and emphasizing the ease of access through Phantom Wallet. Discussions suggest buyers are actively accumulating, anticipating a significant move, with some viewing it as a hidden gem within the crypto space. The community speculates about a potential connection to AI.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as investors discuss its price momentum and potential near-term resistance levels, with some eyeing a possible run toward $200. Community members are also weighing in on factors like AI infrastructure deals and potential government shutdowns, considering their impact on the broader market. Additionally, there's chatter around its partnerships with other companies.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending following the announcement of a strategic partnership with Perplexity, an AI search company, sparking speculation about the implications for Rumble's AI capabilities and potential integration with platforms like Truth Social.  The community is actively discussing the high short interest in RUM, with some believing a short squeeze could be imminent. Many are also highlighting Rumble's ties to crypto, Tether's ownership stake, and the potential for government cloud contracts as possible catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

NVST vs. ABT: Which Stock Is the Better Value Option?

Growing Diagnostics Arm Supports ABT Stock, Macro Issues Ail

ABT gains momentum with strong FreeStyle Libre sales and Diagnostics growth but global macro headwinds weigh on performance.

Here's Why Abbott (ABT) Fell More Than Broader Market

In the closing of the recent trading day, Abbott (ABT) stood at $133.89, denoting a -1.47% move from the preceding trading day.

Is it the Right Time to Retain Abbott Stock in Your Portfolio?

ABT's strong Nutrition, Diabetes Care and EPD growth fuel momentum, but macro and currency headwinds challenge its outlook.

Hologic's Strong International Traction to Continue Despite Headwinds

HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.

Abbott (ABT) Gains As Market Dips: What You Should Know

Abbott (ABT) concluded the recent trading session at $132.76, signifying a +1.09% move from its prior day's close.

Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?

The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

Abbott (ABT) concluded the recent trading session at $129.36, signifying a -1.96% move from its prior day's close.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$1.30	--	--	N/A
Q2 '25	$1.25	$1.26	0.42%	BEAT
Q1 '25	$1.07	$1.09	1.66%	BEAT
Q4 '24	$1.33	$1.34	0.41%	BEAT
Q3 '24	$1.20	$1.21	0.65%	BEAT

ABT
Abbott Laboratories

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest ABT News

ABT Abbott Laboratories